Guidance MS is a network-wide solution for managing clinical guidelines and drug stewardship. It provides role-based functionality for medical staff, pharmacists, senior prescribers and stewardship program managers. It is widely used by hospitals to manage drug formularies and to triage patients on high-risk drugs or who have serious conditions needing specialist review. It can be implemented as a standalone system or integrated with other clinical IT systems such as Patient Management, User Security and ePrescribing.
is the only electronic stewardship tool in Australia with independent evaluation in peer-reviewed international publications. A 2008 Journal of Antimicrobial Chemotherapy article demonstrated positive impacts of this system, with reported gradients in the prescribing of third- and fourth-generation cephalosporins, glycopeptides, carbapenems, aminoglycosides and quinolones all decreasing after Guidance MS implementation. Trends in increased susceptibility of Staphylococcus aureus
to methicillin and improved susceptibility of Pseudomonas
species and no increase in adverse outcomes for patients with Gram-negative bacteraemia were observed.
Guidance MS is now well established with proven sustainability and subsequently has been implemented within more than 60 sites nationally. Furthermore, a 2017 Journal of Antimicrobial Chemotherapy
article demonstrated the transferability and ongoing efficacy of this system in a networked environment. It was reported that through a centrally-deployed clinical decision support service, there was a demonstrated decrease in antimicrobial costs, decrease in Clostridium difficile
rates and no observable change in length of stay or mortality.